| Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: thalidomide versus efavirenz as case studies SA Atoyebi, RKR Rajoli, E Adejuyigbe, A Owen, O Bolaji, M Siccardi, ... European Journal of Pharmaceutical Sciences 140, 105068, 2019 | 23 | 2019 |
| Physiologically-based pharmacokinetic modelling of infant exposure to efavirenz through breastfeeding A Olagunju, RKR Rajoli, SA Atoyebi, S Khoo, A Owen, M Siccardi AAS Open Research 1, 16, 2018 | 19 | 2018 |
| Mechanistic modeling of maternal lymphoid and fetal plasma antiretroviral exposure during the third trimester B Shenkoya, S Atoyebi, I Eniayewu, A Akinloye, A Olagunju Frontiers in Pediatrics 9, 734122, 2021 | 10 | 2021 |
| Isolation of novel para-pentyl phenyl benzoate from Mondia whitei.(Hook.F.) skeels (periplocaceae), its structure, synthesis and neuropharmacological evaluation BJ Taiwo, JY Osasan, OO Olubiyi, IA Oyemitan, SAM Atoyebi, ... African Journal of Traditional, Complementary and Alternative Medicines 14 …, 2017 | 10 | 2017 |
| Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy S Atoyebi, F Bunglawala, N Cottura, S Grañana‐Castillo, MC Montanha, ... British journal of clinical pharmacology, 2024 | 9 | 2024 |
| Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using LC-MS/MS A Olagunju, J Nwogu, O Eniayewu, S Atoyebi, A Amara, J Kpamor, ... Authorea Preprints, 2024 | 3 | 2024 |
| Physiologically based pharmacokinetic modeling of drug–drug interactions between ritonavir‐boosted atazanavir and rifampicin in pregnancy S Atoyebi, MC Montanha, R Nakijoba, C Orrell, H Mugerwa, M Siccardi, ... CPT: Pharmacometrics & Systems Pharmacology 13 (11), 1967-1977, 2024 | 1 | 2024 |
| Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry A Olagunju, J Nwogu, O Eniayewu, S Atoyebi, A Amara, J Kpamor, ... Wellcome open research 6, 246, 2022 | 1 | 2022 |
| Comparative modeling of fetal exposure to maternal long-acting injectable versus oral daily antipsychotics P Bediako-Kakari, M Monyo, S Atoyebi, A Olagunju medRxiv, 2024.10. 22.24315924, 2024 | | 2024 |
| Physiologically Based Pharmacokinetic Modelling of the Co-administration of Ritonavir-Boosted Atazanavir and Rifampicin in Children Co-treated for HIV and Tuberculosis S Atoyebi, MC Montanha, R Nakijoba, C Orrell, H Mugerwa, M Siccardi, ... | | 2024 |
| USING COMPUTATIONAL MODELS TO AID OPTIMISATION OF THE PHARMACOTHERAPY OF SELECTED ANTIRETROVIRALS IN COMPLEX POPULATIONS S Atoyebi University of Liverpool, 2024 | | 2024 |
| PA-727 Physiologically-based pharmacokinetic modelling of drug-drug interactions between ritonavir-boosted atazanavir and rifampicin in pregnancy S Atoyebi, MC Montanha, L Najjemba, C Orrell, L Jennings, H Mugerwa, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELLING OF LONG-ACTING RILPIVIRINE IN PREGNANCY S Atoyebi, S Granana-Castillo, M Siccardi, C Waitt JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 25, 186-187, 2022 | | 2022 |
| with reservations A Olagunju, J Nwogu, O Eniayewu, S Atoyebi, A Amara, J Kpamor, ... | | 2022 |
